The mucopolysaccharidoses: a success of molecular medicine
- 18 January 2008
- journal article
- review article
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 10, e1
- https://doi.org/10.1017/s1462399408000550
Abstract
The mucopolysaccharidoses represent a devastating group of lysosomal storage diseases affecting approximately 1 in 25 000 individuals. Advances in biochemistry and genetics over the past 25 years have resulted in the identification of the key hydrolases underlying the mucopolysaccharidoses, with subsequent isolation and characterisation of the genes involved. Ultimately these advances have led to the recent development of specific treatment regimens for some of the mucopolysaccharidoses, in the form of direct enzyme replacement. Direct replacement of the defective gene product has been attempted for very few genetic disorders, and thus the experience gained in the lysosomal storage diseases by the development, evaluation and integration of treatment regimens into healthcare is instructive for other rare genetic disorders. This review focuses on the pathophysiology of the mucopolysaccharidoses and highlights the complex biochemical and physiological perturbations that underlie the disease phenotype.Keywords
This publication has 102 references indexed in Scilit:
- Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III BMolecular Genetics and Metabolism, 2007
- Heparan sulphate proteoglycans fine-tune mammalian physiologyNature, 2007
- Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiencyProceedings of the National Academy of Sciences of the United States of America, 2007
- Pregnane X receptor (PXR) activation: A mechanism for neuroprotection in a mouse model of Niemann–Pick C diseaseProceedings of the National Academy of Sciences of the United States of America, 2006
- Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyThe Journal of Pediatrics, 2006
- Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)The Journal of Pediatrics, 2004
- Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase)The Journal of Pediatrics, 2004
- Deposition of tropoelastin into the extracellular matrix requires a competent elastic fiber scaffold but not live cellsMatrix Biology, 2004
- Perlecan Functions in Chondrogenesis: Insights from in vitro and in vivo ModelsCells Tissues Organs, 2004
- Defective Neuromuscular Synaptogenesis in Agrin-Deficient Mutant MiceCell, 1996